Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $407.6M | -- | -- | $1.46 | -- |
| 11/04/2025 | Q3 | $366.9M | $371.5M | -$1.86 | $1.20 | -$3.06 |
| 08/05/2025 | Q2 | $368.6M | $370.9M | $0.94 | $1.22 | -$0.29 |
| 05/06/2025 | Q1 | $367.8M | $372M | -$3.16 | $1.22 | -$4.38 |
| 02/25/2025 | Q4 | $593.3M | $600.7M | -$6.52 | $1.43 | -$7.95 |
| 11/05/2024 | Q3 | $502.8M | $343.3M | $0.18 | $0.84 | -$0.66 |
| 08/06/2024 | Q2 | $493.9M | $343.9M | $0.29 | $0.77 | -$0.47 |
| 05/07/2024 | Q1 | $487.7M | $339.6M | $0.35 | $0.70 | -$0.36 |
| 02/27/2024 | Q4 | $545.7M | $548.9M | $0.63 | $0.95 | -$0.32 |
| 11/07/2023 | Q3 | -- | $478.9M | $0.20 | -- | -- |
| 08/08/2023 | Q2 | -- | $455.3M | $0.29 | -- | -- |
| 05/09/2023 | Q1 | -- | $565M | $0.39 | -- | -- |
| 02/28/2023 | Q4 | -- | $617M | $0.76 | -- | -- |
| 11/08/2022 | Q3 | -- | $549.3M | $0.70 | -- | -- |
| 08/09/2022 | Q2 | -- | $565.3M | $0.33 | -- | -- |
| 05/03/2022 | Q1 | -- | $304.2M | $0.81 | -- | -- |
| 02/15/2022 | Q4 | -- | $327.6M | $1.18 | -- | -- |
| 10/26/2021 | Q3 | -- | $307.4M | $1.00 | -- | -- |
| 07/27/2021 | Q2 | -- | $305.1M | $0.88 | -- | -- |
| 04/27/2021 | Q1 | -- | $299M | $0.92 | -- | -- |
| 02/23/2021 | Q4 | -- | $295.1M | $1.21 | -- | -- |
| 10/27/2020 | Q3 | -- | $278.1M | $0.85 | -- | -- |
| 07/28/2020 | Q2 | -- | $301M | $0.96 | -- | -- |
| 04/28/2020 | Q1 | -- | $269.6M | $1.12 | -- | -- |
| 02/19/2020 | Q4 | -- | $247.5M | $0.92 | -- | -- |
| 10/30/2019 | Q3 | -- | $229M | $0.86 | -- | -- |
| 07/31/2019 | Q2 | -- | $229.7M | $0.79 | -- | -- |
| 05/06/2019 | Q1 | -- | $231.7M | $0.87 | -- | -- |
| 02/26/2019 | Q4 | -- | $223.1M | $0.83 | -- | -- |
| 10/31/2018 | Q3 | -- | $210.6M | $1.02 | -- | -- |
| 08/01/2018 | Q2 | -- | $211.6M | $0.79 | -- | -- |
| 05/02/2018 | Q1 | -- | $213M | $0.82 | -- | -- |
| 02/27/2018 | Q4 | -- | $207.9M | -$0.15 | -- | -- |
| 10/31/2017 | Q3 | -- | $193.4M | $0.64 | -- | -- |
| 08/02/2017 | Q2 | -- | $192.3M | $0.80 | -- | -- |
| 05/03/2017 | Q1 | -- | $196.6M | $0.93 | -- | -- |
| 02/14/2017 | Q4 | -- | $183.2M | $3.97 | -- | -- |
| 11/01/2016 | Q3 | -- | $167.6M | $0.52 | -- | -- |
| 08/03/2016 | Q2 | -- | $172.6M | $0.57 | -- | -- |
| 05/04/2016 | Q1 | -- | $171.2M | $0.53 | -- | -- |
| 02/23/2016 | Q4 | -- | $167.3M | $0.46 | -- | -- |
Masimo Corp. reported $371.5M worth of top line sales in its most recent quarter.
Masimo Corp. announced earnings per share of -$1.86 which represents a miss of analyst forecast a $1.20 per share.
Masimo Corp. reported $230.6M that represents $4.24 per share over the last quarter.
Masimo Corp.'s earnings are forecast to grow from -$5.72 per share to $4.03 per share next year representing an increase of 167.76%.
Masimo Corp.'s next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.